The first day of the public meeting, September 13, 2017, was dedicated to the topic of Stewardship of Antibiotic Prescription and Use. The three working groups on Incentives for Diagnostics, Therapeutics/Anti-Infectives, and Vaccines, reported their final findings to the full Advisory Council for deliberation on the second day of the public meeting, September 14, 2017, and the Advisory Council deliberated and voted on the final report presented. Additionally, federal agencies provided updates on their achievements as stipulated in the goals with corresponding objectives and milestones of the National Action Plan on Combating Antibiotic Resistant Bacteria.
Agenda
Notice
Webcast Information
Archived Webcast:
Meeting Documents
FINAL Incentives Report – September 2017
Presentations
September 13
Patient Story
National Action Plan Goal 1 – Stewardship
- Arjun Srinivasan, Centers for Disease Control and Prevention, HHS
- Shari Ling, Centers for Medicare and Medicaid Services, HHS
- Melissa Miller, Agency for Healthcare Research and Quality, HHS
- David Baker, The Joint Commission
- William “Bill” Flynn, CVM, Food and Drug Administration, HHS
- Gary Roselle, United States Department of Veterans Affairs
- Paige Waterman, United States Department of Defense
- Lynn Filpi, Office of Global Affairs, HHS
- Brian McCluskey, APHIS, United States Department of Agriculture
- Mervalin Morant, NIFA, United States Department of Agriculture
Influencing Stewardship Behavior
- Overview of Behavioral Science Research: Elana Safran, Office of Evaluation Sciences
- Influencing Behavior in Different Settings: Julia Szymczak, University of Pennsylvania
- Long-Term Care Setting: Ghinwa Dumyati, University of Rochester Medical Center
- Pediatric Setting: Rita Mangione-Smith, University of Washington
- Out-Patient Setting: Jeffrey Linder, Northwestern University
- Consumer Messaging: Jasmin Malone, Truth Initiative
September 14
Agency Updates on National Action Plan Infection Prevention and Goals 2 – 5
- Michael Craig, Centers for Disease Control and Prevention, HHS
- William “Bill” Flynn, CVM, Food and Drug Administration, HHS
- Steven Gitterman, OIR, Food and Drug Administration, HHS
- Shari Ling, Centers for Medicare and Medicaid Services, HHS
- James Cleeman, Agency for Healthcare Research and Quality, HHS
- Jane Knisely, National Institutes of Health, HHS
- Joseph Larsen, Biomedical Advanced Research and Development Authority, HHS
- Lynn Filpi, Office of Global Affairs, HHS
- Jessica Petrillo, United States Department of State
- Gary Roselle, United States Department of Veterans Affairs
- Paige Waterman, United States Department of Defense
- Lisa Durso, ARS, United States Department of Agriculture
